A Phase 1 Study of an Investigational Drug, ALN-PCSSC, in Subjects With Elevated Low Density Lipoprotein Cholesterol (LDL-C)

Clinical trial NCT02314442 · COMPLETED

Trial details

NCT number: NCT02314442
Sponsor: Alnylam Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hypercholesterolemia

Start date: 2014-12-01
Primary completion: 2015-05-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.